Evidence map›Paper›PMID 37588136›Full record

ArticleFrontiers in bioengineering and biotechnology2023

Recombinant human TIM-3 ectodomain expressed in bacteria and recovered from inclusion bodies as a stable and active molecule.

G C Lima, R M Chura-Chambi, L Morganti, V J Silva, M P Cabral-Piccin, V Rocha, T S Medina, R N Ramos, D Luz

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

G C LimaLaboratory of Bacteriology, Butantan Institute, São Paulo, Brazil.
R M Chura-ChambiLaboratory of Bacteriology, Butantan Institute, São Paulo, Brazil.
L MorgantiBiotechnology Center, Institute of Energy and Nuclear Research-CNEN/SP, São Paulo, Brazil.
V J SilvaLaboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, Department of Hematology and Cell Therapy, Clinical Hospital, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
M P Cabral-PiccinInternational Research Center, A. C. Camargo Cancer Center, São Paulo, Brazil.
V RochaLaboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, Department of Hematology and Cell Therapy, Clinical Hospital, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
T S MedinaInternational Research Center, A. C. Camargo Cancer Center, São Paulo, Brazil.
R N RamosLaboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, Department of Hematology and Cell Therapy, Clinical Hospital, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
D LuzLaboratory of Bacteriology, Butantan Institute, São Paulo, Brazil.
Instituto Butantan · BRAC Camargo Hospital · BRD’Or Institute for Research and Education · BRNational Nuclear Energy Commission · BRUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

active recombinant proteinbacteria expressioninclusion bodiesmembrane proteinTIM-3

Identifiers

PMID37588136
PMCPMC10426796
OpenAlexW4385429466

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.